Stiff-Person Syndrome is a rare neurological disorder. It causes muscles to become very stiff and prone to sudden, severe spasms. These spasms can happen without warning, triggered by things like noise or touch. The condition usually starts in adulthood and can make it hard to walk or move normally. It can also affect breathing in serious cases.
Every report comes from a Lived member, sent anonymously.
Have you tried Baclofen for Stiff-Person Syndrome?
Stiff-person syndrome (SPS) is a rare neurological disorder that causes muscles to stay abnormally tight and to seize up in painful spasms. Stiffness usually starts in the back, abdomen and legs, and it often comes and goes before becoming more constant. Spasms can arrive without warning or be set off by a sudden noise, a light touch, cold or a strong emotion, and a spasm in the legs can make a person fall. Over time, many people walk slowly and stiffly, and the lower back may become noticeably arched. SPS is thought to be autoimmune: the immune system mistakenly targets nerve cells in the brain and spinal cord that normally calm muscle activity. It is a spectrum rather than one fixed pattern. Some people have stiffness limited to one limb or the trunk, while others develop wider involvement of the brain and brainstem, with problems such as double vision, unsteadiness or slurred speech. Some older names, including congenital stiff-person syndrome and stiff-baby syndrome, actually refer to hereditary hyperekplexia. That is a different, inherited condition that begins in infancy with stiffness and an exaggerated startle, and it is not the same disease as SPS in adults.
The underlying cause of SPS is not fully understood. Most people with it have high levels of antibodies against glutamic acid decarboxylase (GAD), an enzyme that nerve cells use to make gamma-aminobutyric acid (GABA), a chemical messenger that dampens muscle activity. Losing that braking signal is thought to leave muscles switched on, although researchers still debate exactly how much the antibodies themselves cause the damage. Some people have other antibodies, and some have none that current tests can detect. SPS most often begins between the ages of 30 and 60 and affects women about twice as often as men. It frequently occurs alongside other autoimmune conditions, especially type 1 diabetes and thyroid disease, and less often vitiligo or pernicious anemia. In a small number of people, SPS is a reaction to a cancer, most often breast or lung cancer. This form, called paraneoplastic SPS, is more often linked to antibodies against a protein called amphiphysin, and symptoms may appear before the cancer is found. Once SPS is present, everyday stimuli such as noise, being bumped, cold and stress can set off spasms. These are triggers for episodes, not causes of the disease.
There is no single test that settles the diagnosis on its own. A neurologist looks for the characteristic pattern of stiffness and stimulus-triggered spasms, then uses tests to support it and rule out other causes. Because SPS is rare and its early signs can be subtle, it is often mistaken for anxiety, a psychological or functional disorder, Parkinson's disease, multiple sclerosis or fibromyalgia. Anxiety and fear of open spaces are common in SPS and can appear before the muscle symptoms, which adds to the confusion. Delays of a year or more between first symptoms and diagnosis are common. A blood test for GAD antibodies is central. GAD antibodies also occur in type 1 diabetes, usually at lower levels, so the result is interpreted by how high the level is: SPS is typically associated with levels well above those seen in diabetes. Testing spinal fluid can show that the antibodies are being made within the nervous system. Electromyography (EMG), which records electrical activity in muscles through fine needles, can show muscles firing continuously even when the person is trying to relax. Magnetic resonance imaging (MRI) scans of the brain and spine are usually normal in SPS and are mainly used to exclude other problems. When antibodies to amphiphysin are found, or the pattern is unusual, doctors look for an associated cancer, often with computed tomography (CT) scans of the body and breast imaging.
There is currently no cure, but treatment can substantially reduce stiffness and spasms and help people keep moving. Care usually follows two tracks at once: medicines that relax muscles, and therapy that calms the immune attack. For symptoms, benzodiazepines are usually the first choice. Diazepam (Valium) and similar medicines strengthen the GABA signal that SPS weakens. Baclofen, a muscle relaxant, is commonly added, sometimes delivered through a pump into the spinal fluid when tablets are not enough. Other options include gabapentin (a nerve-calming medicine also used for seizures and nerve pain) and tizanidine (another muscle relaxant), and botulinum toxin injections can help stiffness in particular muscles. The main trade-offs are drowsiness and unsteadiness. Because these medicines slow the nervous system, combining them with opioid pain medicines or alcohol can dangerously slow breathing. They also cannot be stopped suddenly: abrupt withdrawal can trigger severe, even life-threatening spasms, so any change is made gradually with the prescriber. Intravenous immunoglobulin (IVIG), an infusion of antibodies collected from donated blood, is the immune treatment with the best evidence. In a randomized trial it reduced stiffness and sensitivity to noise, touch and stress and improved walking and balance. Benefit varies from person to person. For people who do not respond well, options include rituximab (a drug that removes the immune cells that make antibodies), plasma exchange and steroids, though evidence for these is weaker. Stem cell transplant and newer cell therapies are being studied for severe cases at specialized centers. When SPS is linked to cancer, treating the cancer is a central part of care. Physical therapy, gentle stretching, heat and water exercise help maintain movement and balance, and programs are built up cautiously to avoid provoking spasms. Psychological support for anxiety and fear of falling is also a meaningful part of treatment.
SPS usually develops over months to years. It may stay stable for long periods or slowly worsen, and the course differs a great deal between people. Many people reach a point where they need a cane, walker or wheelchair, at least for a time. Treatment can change that picture: in one long-term study of people followed for at least five years, over half lost independence at their worst point, yet most were functionally independent at their latest follow-up. Daily life often involves managing triggers and fall risk. Crowds, unexpected sounds and open spaces can provoke spasms, and some people become reluctant to go out alone. Spasms tend to quiet during sleep. Practical steps such as home safety changes, mobility aids and planning outings can make a real difference, as can support for anxiety, which is common and can worsen symptoms. Care is usually long-term and led by a neurologist, ideally one with experience in SPS or autoimmune neurology. Regular visits track symptoms, walking and treatment response, adjust medicines and immune therapy, and check for related conditions such as diabetes and thyroid disease.
See a doctor, ideally a neurologist, if you have persistent stiffness in the back or legs with painful spasms set off by noise, touch or stress, especially if you also have type 1 diabetes or thyroid disease. If you already have SPS, contact your care team promptly if falls become more frequent, stiffness spreads, or you develop new double vision, slurred speech, trouble swallowing or confusion, which can signal a more aggressive form. Call them as well if you are about to run out of medicine or cannot take it, since stopping suddenly can provoke severe spasms. Get emergency care if severe spasms will not let up after medicine has been missed or stopped. Chest tightness during a spasm is common and usually eases as the spasm passes. Call 911 if breathing does not ease as the spasm relaxes, or if the person cannot speak in full sentences, has bluish lips or becomes confused or very drowsy.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Stiff-Person Syndrome is like, what's helped you, or ask the community a question.